Skip to main content
Top
Published in: General Thoracic and Cardiovascular Surgery 5/2016

01-05-2016 | Case Report

New onset of myasthenia gravis 10 years after proton beam therapy for thymoma

Authors: Takahiro Karasaki, Tomohiro Murakawa, Kazuhiro Nagayama, Jun-ichi Nitadori, Masaki Anraku, Yoshinao Kikuchi, Aya Shinozaki-Ushiku, Hiroshi Igaki, Jun Nakajima

Published in: General Thoracic and Cardiovascular Surgery | Issue 5/2016

Login to get access

Abstract

A 36-year-old woman underwent proton beam therapy for encapsulated type B1 thymoma for curative intent at 66 GyE. Radiographically partial response was achieved. Although the tumor size had been stable since that time, she developed systemic myasthenia gravis 10 years after the proton therapy. Extended thymectomy was performed. There were no adhesions between the tumor and the pericardium, and there were no adhesions also between the tumor and the sternum, probably due to the favor of Bragg peak effect. Extensive hyalinization with small foci of viable tumor cells showing degenerated type A-like morphology was observed in the resected tumor. Whether the viable cells represented recurrence with degenerative changes or de novo tumor formation was unable to be determined, and whether the viable cells were responsible for the onset of myasthenia gravis remained unclear.
Literature
1.
go back to reference Kondo K. Therapy for thymic epithelial tumors. Gen Thorac Cardiovasc Surg. 2014;62:468–74. Kondo K. Therapy for thymic epithelial tumors. Gen Thorac Cardiovasc Surg. 2014;62:468–74.
2.
go back to reference Sakamoto M, Murakawa T, Konoeda C, Inoue Y, Kitano K, Sano A, et al. Survival after extended thymectomy for thymoma. Eur J Cardiothorac Surg. 2012;41:623–7.CrossRefPubMed Sakamoto M, Murakawa T, Konoeda C, Inoue Y, Kitano K, Sano A, et al. Survival after extended thymectomy for thymoma. Eur J Cardiothorac Surg. 2012;41:623–7.CrossRefPubMed
3.
go back to reference Chang JY, Zhang X, Wang X, Kang Y, Riley B, Bilton S, et al. Significant reduction of normal tissue dose by proton radiotherapy compared with three-dimensional conformal or intensity-modulated radiation therapy in Stage I or Stage III non-small-cell lung cancer. Int J Radiat Oncol Biol Phys. 2006;65:1087–96.CrossRefPubMed Chang JY, Zhang X, Wang X, Kang Y, Riley B, Bilton S, et al. Significant reduction of normal tissue dose by proton radiotherapy compared with three-dimensional conformal or intensity-modulated radiation therapy in Stage I or Stage III non-small-cell lung cancer. Int J Radiat Oncol Biol Phys. 2006;65:1087–96.CrossRefPubMed
4.
go back to reference Onuki T, Ishikawa S, Yamamoto T, Ito H, Sakai M, Onizuka M, et al. Pathologic radioresponse of preoperatively irradiated invasive thymomas. J Thorac Oncol. 2008;3:270–6.CrossRefPubMed Onuki T, Ishikawa S, Yamamoto T, Ito H, Sakai M, Onizuka M, et al. Pathologic radioresponse of preoperatively irradiated invasive thymomas. J Thorac Oncol. 2008;3:270–6.CrossRefPubMed
5.
go back to reference Nakagawa K, Asamura H, Sakurai H, Watanabe S, Tsuta K. Does the mode of surgical resection affect the prognosis/recurrence in patients with thymoma? J Surg Oncol. 2014;109:179–83.CrossRefPubMed Nakagawa K, Asamura H, Sakurai H, Watanabe S, Tsuta K. Does the mode of surgical resection affect the prognosis/recurrence in patients with thymoma? J Surg Oncol. 2014;109:179–83.CrossRefPubMed
6.
go back to reference Tseng YC, Hsieh CC, Huang HY, Huang CS, Hsu WH, Huang BS, et al. Is thymectomy necessary in nonmyasthenic patients with early thymoma? J Thorac Oncol. 2013;8:952–8.CrossRefPubMed Tseng YC, Hsieh CC, Huang HY, Huang CS, Hsu WH, Huang BS, et al. Is thymectomy necessary in nonmyasthenic patients with early thymoma? J Thorac Oncol. 2013;8:952–8.CrossRefPubMed
7.
go back to reference Nakajima J, Murakawa T, Fukami T, Sano A, Takamoto S, Ohtsu H. Postthymectomy myasthenia gravis: relationship with thymoma and antiacetylcholine receptor antibody. Ann Thorac Surg. 2008;86:941–5.CrossRefPubMed Nakajima J, Murakawa T, Fukami T, Sano A, Takamoto S, Ohtsu H. Postthymectomy myasthenia gravis: relationship with thymoma and antiacetylcholine receptor antibody. Ann Thorac Surg. 2008;86:941–5.CrossRefPubMed
8.
go back to reference Okumura M, Fujii Y, Shiono H, Inoue M, Minami M, Utsumi T, et al. Immunological function of thymoma and pathogenesis of paraneoplastic myasthenia gravis. Gen Thorac Cardiovasc Surg. 2008;56:143–50.CrossRefPubMed Okumura M, Fujii Y, Shiono H, Inoue M, Minami M, Utsumi T, et al. Immunological function of thymoma and pathogenesis of paraneoplastic myasthenia gravis. Gen Thorac Cardiovasc Surg. 2008;56:143–50.CrossRefPubMed
9.
go back to reference Björk-Eriksson T, Bjelkengren G, Glimelius B. The potentials of proton beam radiation therapy in malignant lymphoma, thymoma and sarcoma. Acta Oncol. 2005;44:913–7.CrossRefPubMed Björk-Eriksson T, Bjelkengren G, Glimelius B. The potentials of proton beam radiation therapy in malignant lymphoma, thymoma and sarcoma. Acta Oncol. 2005;44:913–7.CrossRefPubMed
Metadata
Title
New onset of myasthenia gravis 10 years after proton beam therapy for thymoma
Authors
Takahiro Karasaki
Tomohiro Murakawa
Kazuhiro Nagayama
Jun-ichi Nitadori
Masaki Anraku
Yoshinao Kikuchi
Aya Shinozaki-Ushiku
Hiroshi Igaki
Jun Nakajima
Publication date
01-05-2016
Publisher
Springer Japan
Published in
General Thoracic and Cardiovascular Surgery / Issue 5/2016
Print ISSN: 1863-6705
Electronic ISSN: 1863-6713
DOI
https://doi.org/10.1007/s11748-014-0484-9

Other articles of this Issue 5/2016

General Thoracic and Cardiovascular Surgery 5/2016 Go to the issue